Skip to main content

Adverse Drug Events to Biomedicines

  • Chapter
  • First Online:
Book cover Adverse Events with Biomedicines
  • 1288 Accesses

Abstract

Adverse Drug Events (ADEs) are commonly differentiated in two classes: Type A, as predictable reactions related to the pharmacological properties of the drug in study; Type B, as unpredictable events in predisposed individuals. The former group includes side effects, toxicity of overdose, secondary effects, and drug interactions. Overall, they contribute for about 80–90 % of ADEs. The latter group includes hypersensitivity (immunological) reactions, and non-specific reactions, such as pseudo-allergic (anaphylactoid) reactions and idiosyncrasy, all contributing for the remaining 10–20 % of events [1, 2].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Rawlins M, Thompson W (1991) Mechanisms of adverse drug reactions. In: Davies D (ed) Textbook of adverse drug reactions. Oxford University Press pg, New York, pp 18–45

    Google Scholar 

  2. Schnyder B, Pichler WJ (2009) Mechanisms of drug-induced allergy. Mayo Clin Proc 84:268–272

    Article  PubMed  Google Scholar 

  3. Aronson JK, Ferner RE (2003) Joining the DoTS: new approach to classify adverse drug reactions. BMJ 327:1222–1225

    Article  PubMed  CAS  Google Scholar 

  4. Ferner RE, Butt TF (2012) Adverse drug reactions. Med 40:366–370

    Google Scholar 

  5. French LE Adverse Cutaneous drug eruptions. In : Ring J et al (eds) Chemical Immunology and Allergy, Karger, 97:1–240

    Google Scholar 

  6. Napoleone E (2011) Children and ADRs (Adverse Drug Reactions). Ital J Pediat 36:e1–e5

    Google Scholar 

  7. Horen B, Montastruc J-L and Lapeyre-Mestre (2002) Adverse drug reactions and off-label drug use in pediatric outpatients. Br J Clin Pharmacol 54:665–670

    Google Scholar 

  8. Giezen TJ, Mantel-Teeuwisse AK, Straus SMJM et al (2008) Safety-related regulatory actions for biologicals approved in the United States and the European Union. JAMA 300:1887–1896

    Article  PubMed  CAS  Google Scholar 

  9. Gerber BO, Pichler WJ (2006) Noncovalent interactions of drugs with immune receptors may mediate drug-induced hypersensitivity reactions. AAPS J 8:e160–e165

    Article  PubMed  CAS  Google Scholar 

  10. Lee SJ, Kavanaugh A (2005) Adverse reactions to biologic agents: focus on autoimmune therapies. J Allergy Clin Immunol 116:900–905

    Article  PubMed  CAS  Google Scholar 

  11. Sherer K, Spoerl D, Bircher AJ (2010) Adverse drug reactions to biologics. JDDG 8:411–426

    Google Scholar 

  12. Clarke JB (2010) Mechanisms of adverse drug reactions to biologics. In : Uetrecht J (ed) Adverse Drug Reactions. Handbook of Experimental Pharmacology. Springer, New York 196:453–474

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Giuseppe Tridente .

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Italia

About this chapter

Cite this chapter

Tridente, G. (2014). Adverse Drug Events to Biomedicines. In: Adverse Events with Biomedicines. Springer, Milano. https://doi.org/10.1007/978-88-470-5313-7_2

Download citation

Publish with us

Policies and ethics